New approach to managing genital warts
CC Lopaschuk - Canadian Family Physician, 2013 - cfp.ca
Objective To summarize and determine the appropriate use for the new and old
management tools for genital warts. Sources of information The following databases were …
management tools for genital warts. Sources of information The following databases were …
Imiquimod 5% cream is a safe and effective self-applied treatment for anogenital warts—results of an open-label, multicentre Phase IIIB trial
SM Garland, JW Sellors, A Wikstrom… - … journal of STD & …, 2001 - journals.sagepub.com
Our objective was to determine the efficacy and safety of imiquimod 5% cream in the
treatment of external genital/perianal warts in an open-label Phase IIIB trial. Patients applied …
treatment of external genital/perianal warts in an open-label Phase IIIB trial. Patients applied …
Self-administered interventions for anogenital warts in immunocompetent patients: a systematic review and meta-analysis
RN Werner, L Westfechtel, C Dressler… - Sexually Transmitted …, 2017 - sti.bmj.com
Background Anogenital warts (AGWs, condylomata acuminata) are among the most
common STIs and may severely impact quality of life (QoL). Available treatment options are …
common STIs and may severely impact quality of life (QoL). Available treatment options are …
Economic and humanistic burden of external genital warts
External genital warts (EGW) are a sexually transmitted infection caused by various strains
of human papillomavirus (HPV). Several studies have described the direct and indirect costs …
of human papillomavirus (HPV). Several studies have described the direct and indirect costs …
Treatment of external genital warts at Planned Parenthood Federation of America centers.
P Fine, C Ball, M Pelta, C McIntyre… - The Journal of …, 2007 - europepmc.org
Objective To compare patterns and cost of treating external genital warts (EGW) at 5 major
Planned Parenthood Federation of America (PPFA) affiliates. Study design Charts of 422 …
Planned Parenthood Federation of America (PPFA) affiliates. Study design Charts of 422 …
Therapeutic options for external genital warts
R Vender, M Bourcier, N Bhatia… - Journal of cutaneous …, 2013 - journals.sagepub.com
The primary goal of treatment for external genital warts (EGWs) is to eradicate visible lesions
and address symptoms that may accompany them, but it does not address the underlying …
and address symptoms that may accompany them, but it does not address the underlying …
Management of female genital warts with an analog of imiquimod 2% in cream: a randomized, double‐blind, placebo‐controlled study
TA Syed, OA Ahmadpour, SA Ahmad… - The Journal of …, 1998 - Wiley Online Library
The purpose of this randomized, double‐blind, placebo‐controlled study was to determine
the clinical efficacy and tolerability of an analog of imiquimod (2%) in cream to cure genital …
the clinical efficacy and tolerability of an analog of imiquimod (2%) in cream to cure genital …
Imiquimod in the treatment of cutaneous warts: an evidence-based review
CS Ahn, WW Huang - American journal of clinical dermatology, 2014 - Springer
Introduction Cutaneous warts are highly prevalent lesions caused by the infection of
keratinocytes by different types of human papillomaviruses. Although cutaneous warts are …
keratinocytes by different types of human papillomaviruses. Although cutaneous warts are …
A retrospective analysis of costs and patterns of treatment for external genital warts in the Netherlands
WI van der Meijden, A Notowicz, FB Blog… - Clinical …, 2002 - Elsevier
Background: External genital warts (EGWs) are one of the most common sexually
transmitted infections, but little is known about the treatment patterns or resources used in …
transmitted infections, but little is known about the treatment patterns or resources used in …
Systematic review of imiquimod for the treatment of external genital wart.
The objective of this review is to assess whether imiquimod provides a therapeutic
advantage over placebo (vehicle) or other active therapy used in the treatment of adult …
advantage over placebo (vehicle) or other active therapy used in the treatment of adult …